Skip to main content

VYN 20 (Vyndaqel tafamidis meglumine 20 mg)

Generic Name: tafamidis

Pill with imprint VYN 20 is Yellow, Capsule-shape and has been identified as Vyndaqel tafamidis meglumine 20 mg. It is supplied by Pfizer Inc.

Vyndaqel is used in the treatment of amyloid cardiomyopathy; amyloidogenic transthyretin amyloidosis and belongs to the drug class transthyretin stabilizers. Vyndaqel tafamidis meglumine 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for VYN 20

Vyndaqel

Generic Name
tafamidis
Imprint
VYN 20
Strength
tafamidis meglumine 20 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Transthyretin stabilizers
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-1975

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.